Stock Analyses

Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.

Clear
6,990 stocks · page 20 of 117
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
CABR
Caring Brands, Inc.
Valuation N/A
Consumer Defensive
Price$1.19
Model IV
P/IV
Market implies +123.3%/yr vs model +15.0% · above model
CAC
CAMDEN NATIONAL CORP
Overvalued
Financial Services
Price$57.94
Model IV$40.01
P/IV1.25
Premium +45% Return to IV: -30.9%
CACC
CREDIT ACCEPTANCE CORP
Deeply undervalued
Financial Services
Price$604.24
Model IV$1,312.64
P/IV0.44
Discount 54% Return to IV: +117.2%
Market implies -3.2%/yr vs model +10.4% · below model
CACI
CACI INTERNATIONAL INC /DE/
Undervalued
Technology
Price$621.17
Model IV$699.99
P/IV0.73
Discount 11% Return to IV: +12.7%
Owner yield 3.0% 10-yr IRR 6.3% · grower
Market implies +8.4%/yr vs model +12.8% · below model
CADL
Candel Therapeutics, Inc.
Valuation N/A
Healthcare
Price$10.55
Model IV
P/IV
Market implies +144.9%/yr vs model +2.0% · above model
CAE
CAE INC
Valuation N/A
Technology
Price$23.71
Model IV
P/IV
CAF
Morgan Stanley China A Share Fund, Inc.
Valuation N/A
Unknown
Price$18.41
Model IV
P/IV
CAG
CONAGRA BRANDS INC.
Deeply undervalued
Consumer Defensive
Price$15.13
Model IV$63.78
P/IV0.21
Discount 76% Return to IV: +321.5%
Owner yield 16.4% 10-yr IRR 25.1% · steady
Market implies -15.5%/yr vs model +3.0% · below model
CAH
CARDINAL HEALTH INC
Undervalued
Consumer Defensive
Price$225.38
Model IV$296.64
P/IV0.66
Discount 24% Return to IV: +31.6%
Owner yield 4.6% 10-yr IRR 10.8% · moderate
Market implies +5.4%/yr vs model +11.2% · below model
CAI
Caris Life Sciences, Inc.
Deeply undervalued
Healthcare
Price$24.34
Model IV$37.69
P/IV0.44
Discount 35% Return to IV: +54.8%
Market implies -5.8%/yr vs model +50.0% · below model
CAIIU
Collective Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.09
Model IV
P/IV
CAKE
CHEESECAKE FACTORY INC
Deeply overvalued
Consumer Cyclical
Price$102.70
Model IV$51.46
P/IV1.28
Premium +100% Return to IV: -49.9%
Owner yield 2.1% 10-yr IRR -0.6% · moderate
Market implies +16.7%/yr vs model +9.0% · above model
CAL
CALERES INC
Deeply overvalued
Consumer Cyclical
Price$12.51
Model IV$7.96
P/IV1.83
Premium +57% Return to IV: -36.4%
Owner yield 20.5% 10-yr IRR 33.3% · moderate
Market implies +11.1%/yr vs model +6.2% · above model
CALC
CalciMedica, Inc.
Valuation N/A
Healthcare
Price$1.98
Model IV
P/IV
CALM
CAL-MAINE FOODS INC
Deeply undervalued
Basic Materials
Price$74.39
Model IV$176.07
P/IV0.42
Discount 58% Return to IV: +136.7%
Owner yield 19.2% 10-yr IRR 33.5% · moderate
Market implies -4.6%/yr vs model +8.0% · below model
CALX
CALIX, INC
Deeply overvalued
Communication Services
Price$35.24
Model IV$8.26
P/IV4.81
Premium +327% Return to IV: -76.6%
Market implies +27.4%/yr vs model +9.5% · above model
CALY
Callaway Golf Co
Fairly valued
Consumer Cyclical
Price$15.46
Model IV$15.43
P/IV1.02
Premium +0% Return to IV: -0.2%
Market implies -2.6%/yr vs model +5.8% · below model
CAMP
Camp4 Therapeutics Corp
Valuation N/A
Healthcare
Price$4.25
Model IV
P/IV
Market implies +35.3%/yr vs model +50.0% · below model
CAMT
CAMTEK LTD
Valuation N/A
Healthcare
Price$147.97
Model IV
P/IV
CAN
Canaan Inc.
Valuation N/A
Financial Services
Price$0.34
Model IV
P/IV
Market implies +30.5%/yr vs model +2.0% · above model
CANE
Teucrium Commodity Trust
Valuation N/A
Financial Services
Price$11.52
Model IV
P/IV
CANF
Can-Fite BioPharma Ltd.
Valuation N/A
Healthcare
Price$2.33
Model IV
P/IV
Market implies +30.1%/yr vs model +2.0% · above model
CANG
Cango Inc.
Valuation N/A
Financial Services
Price$1.83
Model IV
P/IV
Market implies +56.2%/yr vs model +2.8% · above model
CAPL
CrossAmerica Partners LP
Deeply undervalued
Consumer Defensive
Price$22.80
Model IV$31.81
P/IV0.68
Discount 28% Return to IV: +39.5%
Owner yield 7.6% 10-yr IRR 11.7% · steady
Market implies -2.3%/yr vs model +3.0% · below model
CAPN
Cayson Acquisition Corp
Valuation N/A
Financial Services
Price$11.18
Model IV
P/IV
CAPNR
Cayson Acquisition Corp
Valuation N/A
Financial Services
Price$0.11
Model IV
P/IV
CAPNU
Cayson Acquisition Corp
Valuation N/A
Financial Services
Price$11.17
Model IV
P/IV
CAPR
CAPRICOR THERAPEUTICS, INC.
Valuation N/A
Healthcare
Price$8.56
Model IV
P/IV
Market implies +43.5%/yr vs model +15.0% · above model
CAPS
Capstone Holding Corp.
Valuation N/A
Industrials
Price$0.17
Model IV
P/IV
Owner yield 22.6% 10-yr IRR 32.4% · steady
Market implies +15.6%/yr vs model +3.0% · above model
CAQ
Cambridge Acquisition Corp.
Valuation N/A
Financial Services
Price$10.03
Model IV
P/IV
CAQUU
Cambridge Acquisition Corp.
Valuation N/A
Financial Services
Price$10.05
Model IV
P/IV
CAQUW
Cambridge Acquisition Corp.
Valuation N/A
Financial Services
Price$0.40
Model IV
P/IV
CAR
AVIS BUDGET GROUP, INC.
Deeply undervalued
Industrials
Price$121.74
Model IV$1,902.84
P/IV0.10
Discount 94% Return to IV: +1,463.0%
Market implies -38.4%/yr vs model +9.8% · below model
CARD
BANK OF MONTREAL /CAN/
Valuation N/A
Financial Services
Price$2.42
Model IV
P/IV
CARE
Carter Bankshares, Inc.
Deeply overvalued
Financial Services
Price$31.14
Model IV$15.93
P/IV1.71
Premium +95% Return to IV: -48.8%
CARG
CarGurus, Inc.
Deeply undervalued
Technology
Price$34.43
Model IV$45.71
P/IV0.65
Discount 25% Return to IV: +32.8%
Owner yield 5.5% 10-yr IRR 10.0% · moderate
Market implies +1.8%/yr vs model +6.8% · below model
CARL
CARLSMED, INC.
Deeply undervalued
Healthcare
Price$14.73
Model IV$17.56
P/IV0.65
Discount 16% Return to IV: +19.2%
Market implies -1.9%/yr vs model +50.0% · below model
CARR
CARRIER GLOBAL Corp
Deeply overvalued
Industrials
Price$53.88
Model IV$31.00
P/IV2.06
Premium +74% Return to IV: -42.5%
Owner yield 3.1% 10-yr IRR 0.4% · steady
Market implies +11.1%/yr vs model +3.8% · above model
CARS
Cars.com Inc.
Deeply undervalued
Technology
Price$11.71
Model IV$28.25
P/IV0.36
Discount 59% Return to IV: +141.3%
Owner yield 19.5% 10-yr IRR 35.1% · moderate
Market implies -6.4%/yr vs model +9.2% · below model
CART
Maplebear Inc.
Deeply undervalued
Technology
Price$51.07
Model IV$95.23
P/IV0.42
Discount 46% Return to IV: +86.5%
Owner yield 4.8% 10-yr IRR 14.4% · grower
Market implies +5.2%/yr vs model +17.3% · below model
CARU
BANK OF MONTREAL /CAN/
Valuation N/A
Financial Services
Price$21.85
Model IV
P/IV
CASH
PATHWARD FINANCIAL, INC.
Fairly valued
Financial Services
Price$79.42
Model IV$75.46
P/IV1.09
Premium +5% Return to IV: -5.0%
CASS
CASS INFORMATION SYSTEMS INC
Deeply overvalued
Technology
Price$55.18
Model IV$33.85
P/IV1.36
Premium +63% Return to IV: -38.7%
Owner yield 3.9% 10-yr IRR 4.1% · steady
Market implies +9.8%/yr vs model +5.0% · above model
CAST
FreeCast, Inc.
Valuation N/A
Technology
Price$1.41
Model IV
P/IV
CASY
CASEYS GENERAL STORES INC
Fairly valued
Consumer Cyclical
Price$597.48
Model IV$532.65
P/IV1.44
Premium +12% Return to IV: -10.9%
Owner yield 2.0% 10-yr IRR 2.3% · grower
Market implies +12.1%/yr vs model +13.8% · in line
CAT
CATERPILLAR INC
Deeply overvalued
Industrials
Price$808.99
Model IV$238.33
P/IV3.43
Premium +239% Return to IV: -70.5%
Owner yield 2.6% 10-yr IRR 0.4% · moderate
Market implies +23.4%/yr vs model +6.9% · above model
CATO
CATO CORP
Valuation N/A
Consumer Cyclical
Price$2.37
Model IV
P/IV
Market implies -36.1%/yr vs model +2.0% · below model
CATX
Perspective Therapeutics, Inc.
Valuation N/A
Healthcare
Price$2.81
Model IV
P/IV
Market implies +68.0%/yr vs model +15.0% · above model
CATY
CATHAY GENERAL BANCORP
Fairly valued
Financial Services
Price$62.01
Model IV$53.26
P/IV1.08
Premium +16% Return to IV: -14.1%
CAVA
CAVA GROUP, INC.
Valuation N/A
Consumer Cyclical
Price$49.99
Model IV
P/IV
Market implies +20.0%/yr vs model +23.9% · below model
CB
Chubb Ltd
Fairly valued
Financial Services
Price$340.64
Model IV$315.47
P/IV0.99
Premium +8% Return to IV: -7.4%
CBAN
COLONY BANKCORP INC
Overvalued
Financial Services
Price$21.46
Model IV$18.65
P/IV1.06
Premium +15% Return to IV: -13.1%
CBAT
CBAK Energy Technology, Inc.
Undervalued
Technology
Price$1.00
Model IV$1.35
P/IV0.59
Discount 26% Return to IV: +35.2%
Owner yield 15.6% 10-yr IRR 35.6% · grower
Market implies +12.5%/yr vs model +25.0% · below model
CBC
Central Bancompany, Inc.
Deeply overvalued
Financial Services
Price$32.41
Model IV$20.15
P/IV1.41
Premium +61% Return to IV: -37.8%
CBFV
CB Financial Services, Inc.
Deeply overvalued
Financial Services
Price$36.70
Model IV$25.53
P/IV1.40
Premium +44% Return to IV: -30.4%
CBIO
CRESCENT BIOPHARMA, INC.
Valuation N/A
Healthcare
Price$19.41
Model IV
P/IV
Market implies +17.0%/yr vs model +50.0% · below model
CBK
Commercial Bancgroup, Inc.
Fairly valued
Financial Services
Price$33.34
Model IV$34.26
P/IV0.84
Discount 3% Return to IV: +2.8%
CBL
CBL & ASSOCIATES PROPERTIES INC
Fairly valued
Financial Services
Price$54.73
Model IV$50.71
P/IV0.95
Premium +8% Return to IV: -7.3%
CBLL
Ceribell, Inc.
Deeply overvalued
Healthcare
Price$24.33
Model IV$8.64
P/IV2.14
Premium +182% Return to IV: -64.5%
Market implies +14.5%/yr vs model +40.3% · below model
CBNA
CHAIN BRIDGE BANCORP INC
Overvalued
Financial Services
Price$46.32
Model IV$30.60
P/IV1.18
Premium +51% Return to IV: -33.9%